Latest News and Press Releases
Want to stay updated on the latest news?
-
Romeoville, Ill., March 27, 2023 (GLOBE NEWSWIRE) -- Nanophase Technologies Announces Fourth Quarter and Year End 2022Financial Release and Conference Call Details Nanophase Technologies...
-
ROMEOVILLE, Ill., March 02, 2023 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX) has been named to Fast Company’s prestigious annual list of the World’s Most Innovative...
-
ROMEOVILLE, Ill., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and...
-
— Delivered $9.7 million in Q3 revenue — In Beauty Science markets, Solésence revenue is up 39% YOY — In Personal Care Ingredients markets, Nanophase revenue is up 61% YOY ROMEOVILLE, Ill.,...
-
Romeoville, Ill., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty...
-
ROMEOVILLE, Ill., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and...
-
ROMEOVILLE, Ill., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and...
-
ROMEOVILLE, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and...
-
ROMEOVILLE, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and...
-
— Delivered a record $11.2 million in Q2 revenue— In Beauty Science markets, Solésence revenue is up 44% YOY while Active Pharmaceutical Ingredients (API) sales are up 79% ROMEOVILLE, Ill., Aug. ...